Interventional cardiology, peripheral vascular devices market to reach $25 billion by 2022

Sarah Sipek | | Cardiovascular Business | Economics

The market for interventional cardiology and peripheral vascular devices is expected to grow at a compound annual growth rate of 9.7 percent from 2016 to 2022, reaching $25 billion by 2022.

According a study from Allied Market Research (AMR), angioplasty stent systems are estimated to generate the highest revenue among all segments throughout the forecast period due to technological advancements and development of bioabsorbable stents.

North America held the leading position in the global market in 2015—and is expected to maintain its lead going forward. The ranking is attributed to the increase in incidence of heart failures, changes in lifestyle and high adoption of interventional cardiology and peripheral vascular devices in the region.

"Bioabsorbable stents and drug eluting balloons would propel the market growth with a very high rate as these devices get absorbed within the body and therefore eliminate the chances of restenosis within arteries" Hemali Narkhede, Manager, Healthcare Research at AMR, said. "These devices provide better treatment options when compared to conventional stents and balloons," she further added.

Growth in geriatric population, increase in prevalence of chronic diseases, changes in lifestyle of the people, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures and increase in patient awareness are driving the market growth.

However, stringent approval process for interventional cardiology and peripheral vascular devices is a major factor that hampers the market growth.

Bioabsorbable stents system is expected to register a very high compound annual growth rate of 46 percent over the next six years as this system is fully absorbed into the body and eliminates chances of restenosis. 

Sarah Sipek

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."